Stocks and Investing
Stocks and Investing
Fri, February 26, 2021
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
Thu, February 25, 2021
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
Sean Wieland Maintained (TDOC) at Buy with Decreased Target to $291 on, Feb 25th, 2021
Sean Wieland of Piper Sandler, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $305 to $291 on, Feb 25th, 2021.
Sean has made no other calls on TDOC in the last 4 months.
There are 6 other peers that have a rating on TDOC. Out of the 6 peers that are also analyzing TDOC, 3 agree with Sean's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Schoenhaus of "Stephens & Co." Downgraded from Buy to Hold on, Monday, December 7th, 2020
- Robert Jones of "Goldman Sachs" Initiated at Hold and Held Target at $206 on, Friday, December 4th, 2020
- Jamie Stockton of "Wells Fargo" Maintained at Hold with Increased Target to $200 on, Thursday, October 29th, 2020
These are the ratings of the 3 analyists that currently disagree with Sean
- David Larsen of "BTIG" Initiated at Strong Buy and Held Target at $240 on, Thursday, January 7th, 2021
- Matthew Gillmor of "Baird" Upgraded from Hold to Buy and Held Target at $220 on, Friday, November 13th, 2020
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $261 on, Thursday, October 29th, 2020
Contributing Sources